Skip to main
EKSO

EKSO Earnings Dates & Reports

EKSO Most Recent Earnings

Report Date
Period EndingQ4 2025
Est. EPS-$0.15
Actual EPS-$1.56
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

EKSO Earnings per Share (EPS) History

Signup for full access
Browse free

EKSO Latest Earnings

The value each EKSO share was expected to gain vs. the value each share gained.

EKSO reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of -$1.56. This exceeded analysts' expectations of -$0.15 by 940.00%, marking a Miss.

For comparison, Ekso Bionics Hlds reported EPS of -$2.10 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.11.

EKSO Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2026
-$0.11
Q4 2025
-$0.15-$1.56+940.00%
Q3 2025
-$0.97-$0.54-44.33%
Q2 2025
-$1.20-$1.24+3.33%
Q1 2025
-$1.65-$1.80+9.09%
View all

EKSO Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Ekso Bionics Hlds’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

EKSO Earnings FAQs

EKSO last reported earnings on Feb 23, 2026 for Q4 2025, posting an EPS of -$1.56, which Miss the estimate of -$0.15 by 940.00%.

For Q4 2025, EKSO reported an EPS of -$1.56, missing analysts' estimate of -$0.15 by 940.00%.

For Q4 2025, EKSO Miss expectations with an actual EPS of -$1.56 vs. an estimated EPS of -$0.15.

Following the last earnings report on Feb 23, 2026, EKSO's stock price moved — from — to —.

The next EKSO earnings call is scheduled for May. 4, 2026, where executives will discuss financial results and outlook.

Ekso Bionics Hlds (EKSO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.